APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glucagon Drug Industry Growth and Trends Forecast to 2032

2 January 202672 pages

Choose your research edition.

Industry ResearchGlucagon Drug Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Drug Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Glucagon Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Glucagon Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glucagon Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glucagon Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucagon Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucagon Drug include Eli Lilly, Fresenius Kabi, Torrent Labs and Novo Nordisk, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glucagon Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glucagon Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glucagon Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glucagon Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glucagon Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glucagon Drug Market by Company

Eli Lilly

Fresenius Kabi

Torrent Labs

Novo Nordisk

Glucagon Drug Segment by Type

Inject Glucagon

Nasal Glucagon

Glucagon Drug Segment by Application

Cardiogenic Shock

General Use

Emergency Kits

Diagnostic & Motility

Others

Glucagon Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucagon Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glucagon Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inject Glucagon Table 2. Major Company of Nasal Glucagon Table 3. Global Glucagon Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Glucagon Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Glucagon Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Glucagon Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Glucagon Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Glucagon Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Glucagon Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Glucagon Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Glucagon Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Glucagon Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Glucagon Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Glucagon Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Glucagon Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Glucagon Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Glucagon Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Glucagon Drug Industry Trends Table 25. Glucagon Drug Industry Drivers Table 26. Glucagon Drug Industry Opportunities and Challenges Table 27. Glucagon Drug Industry Restraints Table 28. Global Glucagon Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Glucagon Drug Revenue Market Share by Company (2021-2026) Table 30. Global Glucagon Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Glucagon Drug Sales Share by Company (2021-2026) Table 32. Global Glucagon Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Glucagon Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Glucagon Drug Major Company Production Sites and Headquarters Table 35. Global Glucagon Drug Company, Product Type & Application Table 36. Global Glucagon Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Glucagon Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Glucagon Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Glucagon Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Glucagon Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Glucagon Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Glucagon Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Glucagon Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Glucagon Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Glucagon Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Glucagon Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Glucagon Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Glucagon Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Glucagon Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Glucagon Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Glucagon Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Glucagon Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Glucagon Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Glucagon Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Glucagon Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Glucagon Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Glucagon Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Glucagon Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Glucagon Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Glucagon Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Glucagon Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Glucagon Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Glucagon Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Eli Lilly Company Information Table 72. Eli Lilly Business Overview Table 73. Eli Lilly Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Eli Lilly Glucagon Drug Product Portfolio Table 75. Eli Lilly Recent Development Table 76. Fresenius Kabi Company Information Table 77. Fresenius Kabi Business Overview Table 78. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Fresenius Kabi Glucagon Drug Product Portfolio Table 80. Fresenius Kabi Recent Development Table 81. Torrent Labs Company Information Table 82. Torrent Labs Business Overview Table 83. Torrent Labs Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Torrent Labs Glucagon Drug Product Portfolio Table 85. Torrent Labs Recent Development Table 86. Novo Nordisk Company Information Table 87. Novo Nordisk Business Overview Table 88. Novo Nordisk Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Novo Nordisk Glucagon Drug Product Portfolio Table 90. Novo Nordisk Recent Development Table 91. North America Glucagon Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 93. North America Glucagon Drug Sales Market Share by Country (2021-2026) Table 94. North America Glucagon Drug Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Glucagon Drug Sales Market Share Forecast by Country (2027-2032) Table 96. North America Glucagon Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Glucagon Drug Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Glucagon Drug Market Share by Country (2021-2026) Table 99. North America Glucagon Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Glucagon Drug Market Share Forecast by Country (2027-2032) Table 101. Europe Glucagon Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 103. Europe Glucagon Drug Sales Market Share by Country (2021-2026) Table 104. Europe Glucagon Drug Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Glucagon Drug Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Glucagon Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Glucagon Drug Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Glucagon Drug Market Share by Country (2021-2026) Table 109. Europe Glucagon Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Glucagon Drug Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Glucagon Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Glucagon Drug Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Glucagon Drug Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Glucagon Drug Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Glucagon Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Glucagon Drug Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Glucagon Drug Market Share by Country (2021-2026) Table 119. Asia-Pacific Glucagon Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Glucagon Drug Market Share Forecast by Country (2027-2032) Table 121. Latin America Glucagon Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 123. Latin America Glucagon Drug Sales Market Share by Country (2021-2026) Table 124. Latin America Glucagon Drug Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Glucagon Drug Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Glucagon Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Glucagon Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Glucagon Drug Market Share by Country (2021-2026) Table 129. Latin America Glucagon Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Glucagon Drug Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Glucagon Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Glucagon Drug Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Glucagon Drug Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Glucagon Drug Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Glucagon Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Glucagon Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Glucagon Drug Market Share by Country (2021-2026) Table 139. Middle East and Africa Glucagon Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Glucagon Drug Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Glucagon Drug Distributors List Table 144. Glucagon Drug Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Glucagon Drug Image Figure 2. Global Glucagon Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucagon Drug Sales (2021-2032) & (K Units) Figure 5. Inject Glucagon Image Figure 6. Global Inject Glucagon Sales YoY Growth (2021-2032) & (K Units) Figure 7. Nasal Glucagon Image Figure 8. Global Nasal Glucagon Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Glucagon Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Glucagon Drug Market Share by Type 2025 VS 2032 Figure 11. North America Glucagon Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Glucagon Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Glucagon Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Glucagon Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Glucagon Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Glucagon Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Glucagon Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Glucagon Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Glucagon Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Glucagon Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Glucagon Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cardiogenic Shock Image Figure 24. Global Cardiogenic Shock Sales YoY Growth (2021-2032) & (K Units) Figure 25. General Use Image Figure 26. Global General Use Sales YoY Growth (2021-2032) & (K Units) Figure 27. Emergency Kits Image Figure 28. Global Emergency Kits Sales YoY Growth (2021-2032) & (K Units) Figure 29. Diagnostic & Motility Image Figure 30. Global Diagnostic & Motility Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Glucagon Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Glucagon Drug Market Share by Application 2025 VS 2032 Figure 35. North America Glucagon Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Glucagon Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Glucagon Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Glucagon Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Glucagon Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Glucagon Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Glucagon Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Glucagon Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Glucagon Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Glucagon Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Glucagon Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Glucagon Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Glucagon Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Glucagon Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Glucagon Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Glucagon Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Glucagon Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Glucagon Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Glucagon Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Glucagon Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Glucagon Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Glucagon Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Glucagon Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Glucagon Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Glucagon Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Glucagon Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Glucagon Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Glucagon Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Glucagon Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Glucagon Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Glucagon Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Glucagon Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Inject Glucagon
  • Nasal Glucagon
Applications
  • Cardiogenic Shock
  • General Use
  • Emergency Kits
  • Diagnostic & Motility
  • Others
Companies covered
  • Eli Lilly
  • Fresenius Kabi
  • Torrent Labs
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucagon Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glucagon Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glucagon Drug Market by Type
  6. 1.3.1 Inject Glucagon
  7. 1.3.2 Nasal Glucagon
  8. 1.4 Global Glucagon Drug Market Size by Type
  9. 1.4.1 Global Glucagon Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Glucagon Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Glucagon Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Glucagon Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Glucagon Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Glucagon Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Glucagon Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Glucagon Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glucagon Drug Industry Trends
  2. 2.2 Glucagon Drug Industry Drivers
  3. 2.3 Glucagon Drug Industry Opportunities and Challenges
  4. 2.4 Glucagon Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glucagon Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Glucagon Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Glucagon Drug Price (2021-2026)
  4. 3.4 Global Glucagon Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucagon Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Glucagon Drug Company, Product Type & Application
  7. 3.7 Global Glucagon Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucagon Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucagon Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucagon Drug Tier 1, Tier 2, and Tier 3
4 Glucagon Drug Regional Status and Outlook
  1. 4.1 Global Glucagon Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glucagon Drug Historic Market Size by Region
  3. 4.2.1 Global Glucagon Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glucagon Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glucagon Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glucagon Drug Forecasted Market Size by Region
  7. 4.3.1 Global Glucagon Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glucagon Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glucagon Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glucagon Drug by Application
  1. 5.1 Glucagon Drug Market by Application
  2. 5.1.1 Cardiogenic Shock
  3. 5.1.2 General Use
  4. 5.1.3 Emergency Kits
  5. 5.1.4 Diagnostic & Motility
  6. 5.1.5 Others
  7. 5.2 Global Glucagon Drug Market Size by Application
  8. 5.2.1 Global Glucagon Drug Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Glucagon Drug Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Glucagon Drug Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Glucagon Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Glucagon Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Glucagon Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Glucagon Drug Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Glucagon Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly
  2. 6.1.1 Eli Lilly Company Information
  3. 6.1.2 Eli Lilly Business Overview
  4. 6.1.3 Eli Lilly Glucagon Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly Glucagon Drug Product Portfolio
  6. 6.1.5 Eli Lilly Recent Developments
  7. 6.2 Fresenius Kabi
  8. 6.2.1 Fresenius Kabi Company Information
  9. 6.2.2 Fresenius Kabi Business Overview
  10. 6.2.3 Fresenius Kabi Glucagon Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Fresenius Kabi Glucagon Drug Product Portfolio
  12. 6.2.5 Fresenius Kabi Recent Developments
  13. 6.3 Torrent Labs
  14. 6.3.1 Torrent Labs Company Information
  15. 6.3.2 Torrent Labs Business Overview
  16. 6.3.3 Torrent Labs Glucagon Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Torrent Labs Glucagon Drug Product Portfolio
  18. 6.3.5 Torrent Labs Recent Developments
  19. 6.4 Novo Nordisk
  20. 6.4.1 Novo Nordisk Company Information
  21. 6.4.2 Novo Nordisk Business Overview
  22. 6.4.3 Novo Nordisk Glucagon Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novo Nordisk Glucagon Drug Product Portfolio
  24. 6.4.5 Novo Nordisk Recent Developments
7 North America by Country
  1. 7.1 North America Glucagon Drug Sales by Country
  2. 7.1.1 North America Glucagon Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glucagon Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Glucagon Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glucagon Drug Market Size by Country
  6. 7.2.1 North America Glucagon Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glucagon Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Glucagon Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glucagon Drug Sales by Country
  2. 8.1.1 Europe Glucagon Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glucagon Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Glucagon Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glucagon Drug Market Size by Country
  6. 8.2.1 Europe Glucagon Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glucagon Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glucagon Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glucagon Drug Sales by Country
  2. 9.1.1 Asia-Pacific Glucagon Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glucagon Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glucagon Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glucagon Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Glucagon Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glucagon Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glucagon Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glucagon Drug Sales by Country
  2. 10.1.1 South America Glucagon Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glucagon Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Glucagon Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glucagon Drug Market Size by Country
  6. 10.2.1 South America Glucagon Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glucagon Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Glucagon Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glucagon Drug Sales by Country
  2. 11.1.1 Middle East and Africa Glucagon Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glucagon Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glucagon Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glucagon Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Glucagon Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glucagon Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glucagon Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glucagon Drug Value Chain Analysis
  2. 12.1.1 Glucagon Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glucagon Drug Production Mode & Process
  7. 12.2 Glucagon Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glucagon Drug Distributors
  10. 12.2.3 Glucagon Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst